nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—HTR1B—attention deficit hyperactivity disorder	0.82	1	CbGaD
Penbutolol—ORM1—saliva—attention deficit hyperactivity disorder	0.009	0.274	CbGeAlD
Penbutolol—HTR1B—forebrain—attention deficit hyperactivity disorder	0.00201	0.0611	CbGeAlD
Penbutolol—ADRB1—forebrain—attention deficit hyperactivity disorder	0.00189	0.0575	CbGeAlD
Penbutolol—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.0017	0.0517	CbGeAlD
Penbutolol—HTR1A—forebrain—attention deficit hyperactivity disorder	0.00162	0.0493	CbGeAlD
Penbutolol—ADRB1—cardiovascular system—attention deficit hyperactivity disorder	0.0016	0.0486	CbGeAlD
Penbutolol—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.00137	0.0417	CbGeAlD
Penbutolol—HTR1B—midbrain—attention deficit hyperactivity disorder	0.00133	0.0404	CbGeAlD
Penbutolol—ORM1—nervous system—attention deficit hyperactivity disorder	0.00117	0.0354	CbGeAlD
Penbutolol—ORM1—central nervous system—attention deficit hyperactivity disorder	0.00112	0.0341	CbGeAlD
Penbutolol—HTR1B—nervous system—attention deficit hyperactivity disorder	0.00109	0.0332	CbGeAlD
Penbutolol—HTR1A—midbrain—attention deficit hyperactivity disorder	0.00107	0.0326	CbGeAlD
Penbutolol—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.00105	0.032	CbGeAlD
Penbutolol—ADRB1—nervous system—attention deficit hyperactivity disorder	0.00103	0.0312	CbGeAlD
Penbutolol—ADRB1—central nervous system—attention deficit hyperactivity disorder	0.00099	0.0301	CbGeAlD
Penbutolol—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000882	0.0268	CbGeAlD
Penbutolol—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000849	0.0258	CbGeAlD
Penbutolol—HTR1B—brain—attention deficit hyperactivity disorder	0.000835	0.0254	CbGeAlD
Penbutolol—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.00083	0.0252	CbGeAlD
Penbutolol—ADRB1—brain—attention deficit hyperactivity disorder	0.000786	0.0239	CbGeAlD
Penbutolol—HTR1A—brain—attention deficit hyperactivity disorder	0.000674	0.0205	CbGeAlD
Penbutolol—HTR1B—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000249	0.00169	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000249	0.00169	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000246	0.00167	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000245	0.00166	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000241	0.00164	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000238	0.00162	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000236	0.0016	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000234	0.00159	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000232	0.00158	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000232	0.00157	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000231	0.00157	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000231	0.00157	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000227	0.00154	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000227	0.00154	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000223	0.00151	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000222	0.00151	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000222	0.0015	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000217	0.00148	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000217	0.00147	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000215	0.00146	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000211	0.00143	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000211	0.00143	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000211	0.00143	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000207	0.0014	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000206	0.0014	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000204	0.00139	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000204	0.00138	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000202	0.00137	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000202	0.00137	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000201	0.00136	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000198	0.00135	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000198	0.00134	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000198	0.00134	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000196	0.00133	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000196	0.00133	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000195	0.00133	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000192	0.00131	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000192	0.0013	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000191	0.0013	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00019	0.00129	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00019	0.00129	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000187	0.00127	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000187	0.00127	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000187	0.00127	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000186	0.00126	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000185	0.00125	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000184	0.00125	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000182	0.00124	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000182	0.00123	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000181	0.00123	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00018	0.00122	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000178	0.00121	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000177	0.0012	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000177	0.0012	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000177	0.0012	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000176	0.0012	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000173	0.00118	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000173	0.00117	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000172	0.00117	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000172	0.00117	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00017	0.00115	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000168	0.00114	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000168	0.00114	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000164	0.00112	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000164	0.00112	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000164	0.00111	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000163	0.0011	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000161	0.00109	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000161	0.00109	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000161	0.00109	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00016	0.00109	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000159	0.00108	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000158	0.00107	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000157	0.00107	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000156	0.00106	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000156	0.00106	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000155	0.00106	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000154	0.00105	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000154	0.00105	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000153	0.00104	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000153	0.00104	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000151	0.00103	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000151	0.00102	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000151	0.00102	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00015	0.00102	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000149	0.00101	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000147	0.000999	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000146	0.000993	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000144	0.000977	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000141	0.000955	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000141	0.000955	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000138	0.000934	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000135	0.000913	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000132	0.000893	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000131	0.000893	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000131	0.000889	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000129	0.000878	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000128	0.000871	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000128	0.00087	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000128	0.000868	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000125	0.000852	CbGpPWpGaD
Penbutolol—Propranolol—HTR1B—attention deficit hyperactivity disorder	0.000125	1	CrCbGaD
Penbutolol—HTR1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000125	0.00085	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000125	0.000849	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000124	0.000841	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000123	0.000833	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000122	0.00083	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000122	0.000826	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000121	0.000822	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00012	0.000816	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00012	0.000816	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000119	0.000808	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000119	0.000807	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000118	0.000804	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000118	0.000798	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000118	0.000798	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000116	0.000791	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000116	0.000791	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000116	0.00079	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000115	0.000781	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000115	0.000781	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000114	0.000774	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000114	0.000772	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000112	0.00076	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000112	0.000758	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000111	0.000757	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00011	0.000744	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000107	0.000727	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000105	0.000711	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000103	0.000699	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000103	0.000697	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000102	0.000696	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000101	0.000688	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000101	0.000684	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0001	0.00068	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	9.85e-05	0.000669	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	9.85e-05	0.000669	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	9.11e-05	0.000619	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	9.07e-05	0.000616	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	8.89e-05	0.000604	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	8.82e-05	0.000599	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	8.78e-05	0.000597	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	8.7e-05	0.000591	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	8.64e-05	0.000587	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	8.64e-05	0.000586	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	8.53e-05	0.000579	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	8.5e-05	0.000578	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	8.47e-05	0.000575	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	8.24e-05	0.000559	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	8.17e-05	0.000555	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	8.07e-05	0.000548	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	8e-05	0.000543	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	7.98e-05	0.000542	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	7.94e-05	0.00054	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	7.9e-05	0.000536	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	7.84e-05	0.000533	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	7.84e-05	0.000533	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	7.82e-05	0.000531	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	7.77e-05	0.000528	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	7.74e-05	0.000526	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	7.72e-05	0.000524	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	7.67e-05	0.000521	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	7.6e-05	0.000516	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	7.5e-05	0.000509	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	7.43e-05	0.000505	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	7.22e-05	0.000491	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	7.21e-05	0.00049	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	7.07e-05	0.00048	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	7.06e-05	0.000479	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	7.02e-05	0.000477	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	7e-05	0.000475	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.91e-05	0.000469	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	6.9e-05	0.000469	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	6.88e-05	0.000467	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	6.88e-05	0.000467	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	6.87e-05	0.000467	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	6.84e-05	0.000465	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.79e-05	0.000461	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	6.75e-05	0.000458	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6.75e-05	0.000458	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	6.73e-05	0.000457	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	6.73e-05	0.000457	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	6.72e-05	0.000456	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	6.69e-05	0.000454	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.64e-05	0.000451	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6.6e-05	0.000448	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	6.58e-05	0.000447	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	6.58e-05	0.000447	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	6.56e-05	0.000446	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.5e-05	0.000441	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6.45e-05	0.000438	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	6.42e-05	0.000436	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	6.35e-05	0.000431	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	6.33e-05	0.00043	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	6.27e-05	0.000426	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	6.25e-05	0.000424	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	6.22e-05	0.000422	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	6.19e-05	0.00042	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	6.17e-05	0.000419	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	6.11e-05	0.000415	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	6.08e-05	0.000413	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	6.05e-05	0.000411	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	6.03e-05	0.00041	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.99e-05	0.000407	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.97e-05	0.000406	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.9e-05	0.000401	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.75e-05	0.00039	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.62e-05	0.000382	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.56e-05	0.000378	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.5e-05	0.000373	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.05e-05	0.000343	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.87e-05	0.00033	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.77e-05	0.000324	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.71e-05	0.00032	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.67e-05	0.000317	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.63e-05	0.000315	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.57e-05	0.000311	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.56e-05	0.00031	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.43e-05	0.000301	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.34e-05	0.000294	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.26e-05	0.000289	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.24e-05	0.000288	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.17e-05	0.000283	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.08e-05	0.000277	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.02e-05	0.000273	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.99e-05	0.000271	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.94e-05	0.000267	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.88e-05	0.000263	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.85e-05	0.000261	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.79e-05	0.000257	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.75e-05	0.000255	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.71e-05	0.000252	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.69e-05	0.000251	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.67e-05	0.000249	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.64e-05	0.000247	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.61e-05	0.000245	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.59e-05	0.000244	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.56e-05	0.000242	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.53e-05	0.00024	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.49e-05	0.000237	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.39e-05	0.000231	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.32e-05	0.000225	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.25e-05	0.00022	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.98e-05	0.000203	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.38e-05	0.000161	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.33e-05	0.000158	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.27e-05	0.000154	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.58e-05	0.000107	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.26e-05	8.55e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.23e-05	8.37e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.2e-05	8.18e-05	CbGpPWpGaD
